Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-07-14
1996-10-08
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536122, A61K 3172, A61K 31735, C07H 510
Patent
active
055631258
ABSTRACT:
The compounds 5'-deoxy-5'-(hydroxyethylthio)adenosine (HETA); 5'-deoxy-5'-(monofluoroethylthio)adenosine (MFETA); 5'-deoxy-5'-(chloroethylthio)adenosine (CETA); 5'-deoxy-5'-(bromoethylthio)adenosine (BETA); 5-deoxy-5-(monofluoroethylthio)ribose (MFETR); 5-deoxy-5-(chloroethylthio)ribose (CETR); 5-deoxy-5-(bromoethylthio)ribose (BETR) and 5-deoxy-5-(hydroxyethylthio)ribose (HETR), are described as well as their uses in treating infections caused by 5'-deoxy-5'-methylthioadenosine (MTA) phosphorylase-containing pathogenic microorganisms; in treating infections caused by 5-deoxy-5-methylthioribose (MTR) kinase-containing pathogenic microorganism; and for treating neoplastic diseases.
REFERENCES:
patent: 3212954 (1965-10-01), Kuhn et al.
patent: 4242505 (1980-12-01), Kawahara et al.
patent: 4373097 (1983-02-01), Stramentinoli et al.
patent: 4376116 (1983-03-01), Coward et al.
patent: 4454122 (1984-06-01), Stramentinoli et al.
patent: 4558122 (1985-12-01), Gennari
patent: 4621056 (1986-11-01), Gennari
patent: 4820692 (1989-04-01), Riscoe et al.
patent: 4914086 (1990-04-01), Bacchi et al.
patent: 5180714 (1993-01-01), Sufrin et al.
D. L. Kramer et al., "Biological Effects of a Novel Fluorinated Analog of 5'-Dioxy-5'-(methylthio) adenosine (MTA)", Abstract American Association for Cancer Research, May 25-28, 1988, published as vol. 29, Mar. 1988.
J. R. Sufrin, "Synthesis and Antiproliferative Effects of Novel 5'-Fluorinated Analogues of 5'-Deoxy-5'-(methylthio)adenosine", Journal of Medicinal Chemistry, 1989 vol. 32, No. 5., pp. 997-1001.
M. J. Robins et al., "Fluorination at C5' of Nucleosides, Synthesis of the New Class of 5'-Fluoro-5'-S-Aryl (Alkyl) Thionucleosides from Adenosine", Tetrahedron Letters, vol. 29, No. 45, pp. 5729-5732 (1988).
K. Kikugawa et al., "Platelet Aggregation Inhibitors. 2. Inhibition of Platelet Aggregation by 5'-,2-,6-, and 8- Substituted Adenosines.sup.1 ", Journal of Medicinal Chemistry, 1972, vol. 15, No. 4, pp. 387-391.
Hildesheim et al., "Studies on Synthetic Inhibitors of t-RNA Methyl Transferases: Analogs of S-adenosyl Homocysteine", Biochimie, 1973, 55, -541-546.
P. Chiang et al., "S-Adenosyl-L-homocysteine Hydrolase: Analogues of S-Adenosyl-homocysteine as Potential Inhibitors", Molecular Pharmacology, 13, 939-947, 1977.
J. Enouf et al. "Relationship Between Inhibition of Protein Methylase I and Inhibition of Rous Sarcoma Virus-induced Cell Transformation", Cancer Research 39, 4497-4502, Nov. 1979.
C. S. Marvel et al., "The Structure of Propylene Polysulfone", Journal of American Chemical Society, vol. 76, pp. 61-69 (1954).
J. A. Montgomery, "Analogs of 5'-Deoxy-5'-(methylthio) adenosine", Journal of Medicinal Chemistry, 1974, vol. 17, No. 11, pp. 1197-1203.
M. K. Riscoe et al., "Methionine Recycling as a Target for Antiprotozoal Drug Development", Parasitology Today, vol. 5, No. 10, pp. 330-333 (1989).
L. Y. Ghoda et al., "Substrate Specificities of 5'-deoxy-5'- methylthioadenosine phosphorylase from Trypanosoma brucei bruceiand mammalian cells", Molecular and Biochemical Parasitology, 27, pp. 109-118 (1988).
M. K. Riscoe et al., "Analogs of 5-methylthioribose, and novel class of antiprotozoal agents", Antimicrobial Agents and Chemotherapy, Dec. 1988, pp. 1904-1906.
G. W. Koszalka et al., "5'-methylthioadenosine (MTA) Phosphorylase from Promastigotes of Leishmania Donovani", Purine and Pyrimidine Metabolism in Man V, Edited by W. L. Nyhan et al., Plenum Publishing Corporation, 1986.
R. L. Miller et al., "Trypanosoma CruziAdenine Nucleoside Phosphorylase", Biochemical Pharmacology, vol. 36, No. 00, pp. 553-559 (1987).
A. J. Bitonti et al. I , "Cure of Trypanosoma brucei bruceiand Trypanosoma brucei rhodesienseInfections in Mice with an Irreversible Inhibitor of S-Adenosylmethionine Decarboxylase, Antimicrobial Agents and Chemother". 34, 1485, 1990.
A. J. Bitonti et al. II , "Bis(benzyl)polyamine Analogs Inhibit the Growth of Chloroquine-resistant Human Malaria Parasites (Plasmodium falciparum) in vitro and in Combination with .alpha. difluormethylornithine Cure Murine Malaria", Proc. Natl. Acad. Sci., vol. 86, pp. 651-655, Jan. 1989.
K. F. Baum et al., "Purine Deoxynucleoside Salvage in Giardia lamblia", J. Biol. Chem. 264, 21087, (1989).
H. G. Williams-Ashman et al., "Trends in the Biochemical Pharmacology of 5-Deoxy-5'-methylthioadenosine". Biochem. Pharmocol. 31, 277-288 (1982).
T. M. Savarese et al., "Biochemical Considerations in the Design of Analogs of 5'-Deoxy-5' methylthioadenoseine, in 'i Development of Target-Oriented Anticancer Drugs", Y.-C. Chang. ed, Raven Press, New York, pp. 129-142 (1983).
R. Tritapepe et al., "5'-Methylthioadenosine (MTA) for the Topical Treatment of Angiological Disorders", Acta Therapeutics 15, 299, (1989).
J. I. Toohey"Methylthioadenosine Nucleoside Phosphorylase Deficiency in Methylthio-Dependent Cancer Cells", Biochem. Biophys. Res. Cummun. 83, 27, (1978).
J. H. Fitchen et al., "Methylthioadenosine Phosphorylase Deficiency in Human Leukemias and Solid Tumors", Cancer Res. 46, 5409, (1986).
S. T. Traweek et al., "Methylioadenosine Phosphorylase Deficiency in Acute Leukemia: Pathologic, Cytogenetic and Clinical Features", Blood. 71, 1568, (1989).
R. M. Hoffman, "Altered Methionine Metabolism and Transmethylation in Cancer", Anticancer Res. 5, 1, (1985).
T. M. Savarese et al., "Conversion of 5'-Deoxy-eoxy-5'methylthioadenosine and 5'-Deoxy-5'-Deoxy-5'-methylthioinosine to Methionine in Cultured Human Leukemic Cells", Cancer Res. 43, 4699, (1983).
C. J. Bacchi et al., "Parasitic Protozoa and Polyamines, in Inhibition of Polyamine Metabolism", P. P. McCann, A. E. Pegg and A. Sjoerdsma, Eds. Academic Press, Inc., Orlando, Florida, pp. 317-344 (1987).
R. M. Myers et al., "Conversion of 5-S-Ethyl-thio-D-ribose to Ethionine in Klebsiella Pneumoniae", J. Biol. Chem., 264, 10547, (1989).
Hanessian et al., "Procedures for the Direct Replacement of Primary Hydroxyl Groups in Carbohydrates by Halogen", Carbohydrate Research, 24, 45 (1972).
Yoshiro et al., "Preparation of 5'-deoxy-5'-fluoromethylthio ribonucleosides and antitumor agents containing them", CA 110: 58012m (1989).
Paolella et al., "Effect of adenoxylhomocysteine and other analog thioethers on a prokaryotic tRNA (guanine-7)-methyltransferase" CA 97: 211354j (1982).
Cohen, "Comparative Biochemistry and Drug Design for Infectious Desease", Science, vol. 205, (1979) pp. 964--971.
Kikugawa et al., "5'-(Substituted)-5'-deoxyadenosines.", Chem. Abstr., 79, p. 402, Abstr. No. 53743g; abstract of Japanese patent application 48-34900.
Bacchi, C. J. "5'-Alkyl-Substituted Analogs of 5'-Methylthioadenosine as Trypanocides", Antimicrob. Agents Chemother., vol. 35, No. 7, July 1991, pp. 1315-1320.
Sufrin, J. R., "Targeting 5'-Deoxy-5'-(methylthio)adenosine Phosphorylase by 5'-Haloalkyl Analogues of 5'-Deoxy-5'-(methylthio)adenosine", J. Med. Chem., vol. 34, No. 8, Aug. 1991, pp. 2600-2606.
White, M. W. "Structural Analogs of 5'-Methylthioadenosine as Substrates and Inhibitors of 5'-Methylthioadenesine Phospherylase and as Inhibitors of Human Lymphocyte Transformation", Biochem. Pharmacol., vol. 31, No. 4, 1982, pp. 503-507.
Bacchi Cyrus J.
Nathan, deceased Henry
Porter Carl W.
Spiess Arthur J.
Sufrin Janice R.
Crane L. Eric
Dunn Michael L.
Health Research , Inc.
Pace University
Robinson Douglas W.
LandOfFree
5'-deoxy-5'-(substituted)alkylthioribose compounds and their pha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-57091